Hepatitis B Product Relaunch and Promotion

Category
Advisory Board, Biopharma, Blood Disorders, Branding, Digital, Pharmaceutical, Print, Strategy
About This Project

Hepatitis B Drug Relaunch

As AOR, we repositioned and strategized ways to target various HCP groups who treat Hepatitis B. The drug is indicated for post exposure prophylaxis (PEP) of the Hepatitis B virus (HBV) for individuals exposed to through household, needle stick, perinatal and sexual exposure. We utilized brand campaigns, digital campaigns, CRM programs, KOL development, live events, and print marketing to educate and promote the brand that treats PEP of the Hepatitis B virus (HBV).

 

Client

Biotest Pharmaceuticals Corporation, Nabi-HB®

 

Type

Advisory board, branding, campaign, digital and print promotion, educational materials, key messages, program identity

DO YOU HAVE A COMPREHENSIVE PROGRAM TO CONNECT WITH CUSTOMERS?